• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.

作者信息

Hofstra Julia M, Wetzels Jack F M

机构信息

Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

出版信息

Nephrol Dial Transplant. 2010 Jun;25(6):1760-6. doi: 10.1093/ndt/gfq017. Epub 2010 Feb 3.

DOI:10.1093/ndt/gfq017
PMID:20133280
Abstract
摘要

相似文献

1
Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.膜性肾病中的烷化剂：疗效毋庸置疑。
Nephrol Dial Transplant. 2010 Jun;25(6):1760-6. doi: 10.1093/ndt/gfq017. Epub 2010 Feb 3.
2
Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy.苯丁酸氮芥致膜性肾病患者急性肝衰竭
Am J Kidney Dis. 2000 Aug;36(2):401-4. doi: 10.1053/ajkd.2000.8995.
3
Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.免疫抑制治疗对膜性肾病合并肾功能不全患者的疗效
Kidney Int Suppl. 1997 Oct;61:S63-6.
4
[The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].[风湿病学中的免疫抑制剂。长期监测的适应症、结果及问题]
Ann Med Interne (Paris). 1974 Jun-Jul;125(6-7):497-506.
5
A difficult trade off for adults with membranous nephropathy.
BMJ. 2013 Jan 16;346:f248. doi: 10.1136/bmj.f248.
6
The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?特发性膜性肾病的治疗：难题还是困境？
Am J Kidney Dis. 2004 Sep;44(3):562-6.
7
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.特发性膜性肾病免疫抑制治疗的比较有效性和耐受性：一项网状Meta分析。
PLoS One. 2017 Sep 12;12(9):e0184398. doi: 10.1371/journal.pone.0184398. eCollection 2017.
8
Chlorambucil-induced cytomegalovirus infection: a case report.苯丁酸氮芥诱导的巨细胞病毒感染：一例报告
J Med Case Rep. 2014 Aug 20;8:280. doi: 10.1186/1752-1947-8-280.
9
[Treatment of membranous nephropathy with chronic renal insufficiency].[慢性肾功能不全的膜性肾病治疗]
G Ital Nefrol. 2008 Nov-Dec;25 Suppl 44:76-82.
10
Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.口服环磷酰胺和类固醇对膜性肾病伴肾功能不全患者的短期和长期疗效。研究组
Clin Nephrol. 2001 Jul;56(1):1-9.

引用本文的文献

1
Newer B-cell and plasma-cell targeted treatments for rituximab-resistant patients with membranous nephropathy.针对利妥昔单抗耐药的膜性肾病患者的新型B细胞和浆细胞靶向治疗方法。
Clin Kidney J. 2025 Mar 21;18(5):sfaf088. doi: 10.1093/ckj/sfaf088. eCollection 2025 May.
2
Ten tips on immunosuppression in primary membranous nephropathy.原发性膜性肾病免疫抑制治疗的十条建议。
Clin Kidney J. 2024 Apr 29;17(6):sfae129. doi: 10.1093/ckj/sfae129. eCollection 2024 Jun.
3
High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation.
肾移植后他克莫司高暴露与复发性膜性肾病的自发缓解相关。
Clin Kidney J. 2023 Apr 12;16(10):1644-1655. doi: 10.1093/ckj/sfad077. eCollection 2023 Oct.
4
PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.PLA2R-IgG4 抗体作为特发性膜性肾病患者治疗效果和预后评估的预测生物标志物：一项回顾性研究。
PeerJ. 2022 Oct 10;10:e14193. doi: 10.7717/peerj.14193. eCollection 2022.
5
Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.低剂量与高剂量利妥昔单抗方案治疗特发性膜性肾病的疗效及其与七种方案的比较：系统评价和网络荟萃分析。
Int Urol Nephrol. 2023 Mar;55(3):641-651. doi: 10.1007/s11255-022-03372-5. Epub 2022 Sep 25.
6
Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis.特发性膜性肾病伴中重度蛋白尿的治疗：系统评价和网络荟萃分析。
Int J Clin Pract. 2022 Apr 23;2022:4996239. doi: 10.1155/2022/4996239. eCollection 2022.
7
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.原发性膜性肾病及其对利妥昔单抗耐药的治疗进展。
Front Immunol. 2022 May 4;13:859419. doi: 10.3389/fimmu.2022.859419. eCollection 2022.
8
Tetrandrine may treat membranous glomerulopathy via P13K/Akt signaling pathway regulation: therapeutic mechanism validation using Heymann nephritis rat model.汉防己甲素可能通过调控 P13K/Akt 信号通路治疗膜性肾小球病：以 Heymann 肾炎大鼠模型为对象的治疗机制验证。
Bioengineered. 2021 Dec;12(1):6499-6515. doi: 10.1080/21655979.2021.1973862.
9
Helper T Cells in Idiopathic Membranous Nephropathy.特发性膜性肾病中的辅助性 T 细胞。
Front Immunol. 2021 May 20;12:665629. doi: 10.3389/fimmu.2021.665629. eCollection 2021.
10
Idiopathic Membranous Nephropathy and Treatment Related Complications.特发性膜性肾病及治疗相关并发症。
Med Arch. 2020 Jun;74(3):228-232. doi: 10.5455/medarh.2020.74.228-232.